Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcranial Magnetic Stimulation | 33 | 2022 | 413 | 9.240 |
Why?
|
| Cocaine-Related Disorders | 14 | 2018 | 504 | 4.670 |
Why?
|
| Prefrontal Cortex | 20 | 2022 | 639 | 4.360 |
Why?
|
| Frontal Lobe | 7 | 2022 | 156 | 3.520 |
Why?
|
| Magnetic Resonance Imaging | 35 | 2022 | 2222 | 3.220 |
Why?
|
| Brain | 21 | 2022 | 2175 | 3.090 |
Why?
|
| Cues | 15 | 2022 | 654 | 2.620 |
Why?
|
| Gyrus Cinguli | 7 | 2018 | 113 | 2.510 |
Why?
|
| Transcranial Direct Current Stimulation | 7 | 2020 | 111 | 2.470 |
Why?
|
| Substance-Related Disorders | 11 | 2020 | 1241 | 2.170 |
Why?
|
| Corpus Striatum | 6 | 2018 | 278 | 2.140 |
Why?
|
| Nerve Net | 6 | 2021 | 180 | 2.120 |
Why?
|
| Psychomotor Performance | 7 | 2020 | 213 | 2.110 |
Why?
|
| Evoked Potentials, Motor | 6 | 2022 | 63 | 2.110 |
Why?
|
| Motor Cortex | 7 | 2021 | 158 | 1.950 |
Why?
|
| Gray Matter | 3 | 2021 | 57 | 1.890 |
Why?
|
| Cortical Excitability | 3 | 2022 | 7 | 1.710 |
Why?
|
| Cocaine | 6 | 2017 | 555 | 1.640 |
Why?
|
| Alcoholism | 4 | 2021 | 1109 | 1.560 |
Why?
|
| Brain Mapping | 15 | 2021 | 531 | 1.410 |
Why?
|
| Functional Neuroimaging | 7 | 2021 | 82 | 1.380 |
Why?
|
| Sensorimotor Cortex | 3 | 2019 | 18 | 1.310 |
Why?
|
| Chronic Pain | 2 | 2020 | 110 | 1.300 |
Why?
|
| Theta Rhythm | 3 | 2022 | 6 | 1.220 |
Why?
|
| Attention | 3 | 2018 | 225 | 1.130 |
Why?
|
| Tobacco Use Disorder | 7 | 2017 | 432 | 1.100 |
Why?
|
| Connectome | 4 | 2021 | 91 | 1.090 |
Why?
|
| Adult | 37 | 2021 | 21375 | 1.090 |
Why?
|
| Visual Perception | 2 | 2018 | 124 | 1.060 |
Why?
|
| Cerebellum | 3 | 2021 | 103 | 1.050 |
Why?
|
| Motor Activity | 3 | 2020 | 621 | 1.030 |
Why?
|
| Behavior, Addictive | 5 | 2020 | 317 | 1.000 |
Why?
|
| Humans | 64 | 2022 | 68525 | 0.980 |
Why?
|
| Motivation | 3 | 2018 | 561 | 0.950 |
Why?
|
| Putamen | 3 | 2019 | 35 | 0.940 |
Why?
|
| Craving | 5 | 2017 | 200 | 0.910 |
Why?
|
| Male | 41 | 2022 | 37281 | 0.870 |
Why?
|
| Thalamus | 3 | 2018 | 82 | 0.850 |
Why?
|
| Pain Measurement | 4 | 2020 | 328 | 0.850 |
Why?
|
| Neurofeedback | 4 | 2016 | 34 | 0.830 |
Why?
|
| Female | 40 | 2022 | 38015 | 0.820 |
Why?
|
| Young Adult | 16 | 2021 | 5708 | 0.790 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2020 | 6 | 0.780 |
Why?
|
| Head Movements | 1 | 2020 | 12 | 0.770 |
Why?
|
| Dopamine | 1 | 2022 | 474 | 0.730 |
Why?
|
| Caudate Nucleus | 2 | 2018 | 56 | 0.720 |
Why?
|
| Neuroimaging | 3 | 2022 | 122 | 0.720 |
Why?
|
| Deep Brain Stimulation | 2 | 2020 | 71 | 0.720 |
Why?
|
| Addiction Medicine | 1 | 2019 | 3 | 0.710 |
Why?
|
| Parietal Lobe | 2 | 2017 | 59 | 0.710 |
Why?
|
| Cognition Disorders | 3 | 2011 | 342 | 0.710 |
Why?
|
| Oxygen | 5 | 2016 | 386 | 0.700 |
Why?
|
| Opioid-Related Disorders | 2 | 2020 | 298 | 0.690 |
Why?
|
| Equipment Design | 1 | 2020 | 500 | 0.680 |
Why?
|
| Lower Extremity | 1 | 2020 | 153 | 0.680 |
Why?
|
| Acute Pain | 1 | 2019 | 35 | 0.670 |
Why?
|
| Functional Laterality | 5 | 2018 | 240 | 0.650 |
Why?
|
| Middle Aged | 23 | 2021 | 21119 | 0.640 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2022 | 689 | 0.640 |
Why?
|
| Hand | 1 | 2018 | 90 | 0.630 |
Why?
|
| Emotions | 2 | 2016 | 244 | 0.620 |
Why?
|
| Analgesics, Opioid | 2 | 2020 | 498 | 0.600 |
Why?
|
| Pancreatitis | 1 | 2019 | 279 | 0.590 |
Why?
|
| Neural Pathways | 6 | 2019 | 323 | 0.580 |
Why?
|
| Smoking | 5 | 2017 | 1449 | 0.570 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 772 | 0.520 |
Why?
|
| White Matter | 1 | 2018 | 174 | 0.520 |
Why?
|
| Choice Behavior | 1 | 2015 | 85 | 0.520 |
Why?
|
| Social Behavior | 1 | 2015 | 164 | 0.500 |
Why?
|
| Biomarkers | 2 | 2019 | 1593 | 0.490 |
Why?
|
| Sex Characteristics | 1 | 2016 | 295 | 0.480 |
Why?
|
| Visual Cortex | 1 | 2014 | 67 | 0.470 |
Why?
|
| Mental Disorders | 2 | 2018 | 659 | 0.460 |
Why?
|
| Smoking Cessation | 4 | 2017 | 1032 | 0.440 |
Why?
|
| Limbic System | 1 | 2013 | 106 | 0.440 |
Why?
|
| Movement | 3 | 2013 | 179 | 0.440 |
Why?
|
| Gastric Bypass | 1 | 2013 | 83 | 0.440 |
Why?
|
| Executive Function | 1 | 2013 | 106 | 0.440 |
Why?
|
| Neostriatum | 2 | 2010 | 60 | 0.430 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 172 | 0.400 |
Why?
|
| Case-Control Studies | 5 | 2016 | 1548 | 0.390 |
Why?
|
| Weight Loss | 1 | 2013 | 319 | 0.390 |
Why?
|
| Electromyography | 3 | 2021 | 184 | 0.390 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2021 | 86 | 0.350 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2010 | 152 | 0.350 |
Why?
|
| Cerebral Cortex | 3 | 2020 | 415 | 0.340 |
Why?
|
| Single-Blind Method | 3 | 2018 | 249 | 0.330 |
Why?
|
| Parkinson Disease | 2 | 2021 | 272 | 0.300 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 2077 | 0.280 |
Why?
|
| Neural Inhibition | 2 | 2017 | 80 | 0.280 |
Why?
|
| Primates | 2 | 2022 | 14 | 0.270 |
Why?
|
| Reaction Time | 3 | 2010 | 170 | 0.260 |
Why?
|
| Treatment Outcome | 4 | 2020 | 7028 | 0.260 |
Why?
|
| Touch Perception | 2 | 2019 | 18 | 0.260 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2005 | 105 | 0.240 |
Why?
|
| Rest | 2 | 2020 | 78 | 0.230 |
Why?
|
| Cognition | 2 | 2022 | 512 | 0.230 |
Why?
|
| Stroke | 4 | 2022 | 2161 | 0.220 |
Why?
|
| Goals | 1 | 2022 | 65 | 0.210 |
Why?
|
| Pilot Projects | 2 | 2019 | 1341 | 0.210 |
Why?
|
| Marijuana Smoking | 2 | 2015 | 108 | 0.210 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 160 | 0.200 |
Why?
|
| Neurological Rehabilitation | 1 | 2021 | 12 | 0.200 |
Why?
|
| Neurovascular Coupling | 1 | 2021 | 9 | 0.200 |
Why?
|
| Compulsive Behavior | 1 | 2021 | 12 | 0.200 |
Why?
|
| Checklist | 1 | 2022 | 76 | 0.200 |
Why?
|
| Opiate Alkaloids | 1 | 2020 | 6 | 0.200 |
Why?
|
| Cerebrovascular Circulation | 1 | 2022 | 296 | 0.190 |
Why?
|
| Glucose | 1 | 2022 | 307 | 0.190 |
Why?
|
| Mesencephalon | 1 | 2020 | 41 | 0.180 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2020 | 61 | 0.180 |
Why?
|
| Fingers | 2 | 2010 | 39 | 0.170 |
Why?
|
| Action Potentials | 1 | 2020 | 223 | 0.170 |
Why?
|
| Cortical Synchronization | 1 | 2019 | 6 | 0.170 |
Why?
|
| Drug Tolerance | 1 | 2019 | 80 | 0.170 |
Why?
|
| Animals | 6 | 2022 | 20877 | 0.170 |
Why?
|
| Cross-Over Studies | 2 | 2017 | 260 | 0.170 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 142 | 0.170 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 848 | 0.170 |
Why?
|
| Feasibility Studies | 1 | 2021 | 652 | 0.170 |
Why?
|
| Morphine | 1 | 2019 | 76 | 0.170 |
Why?
|
| Brain Waves | 1 | 2019 | 30 | 0.170 |
Why?
|
| Self-Control | 1 | 2018 | 9 | 0.160 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 396 | 0.160 |
Why?
|
| Photic Stimulation | 2 | 2016 | 229 | 0.160 |
Why?
|
| Thinking | 1 | 2018 | 30 | 0.160 |
Why?
|
| Isometric Contraction | 1 | 2018 | 33 | 0.160 |
Why?
|
| Ankle | 1 | 2018 | 45 | 0.160 |
Why?
|
| Anthropometry | 1 | 2018 | 64 | 0.160 |
Why?
|
| Pyramidal Tracts | 1 | 2018 | 45 | 0.160 |
Why?
|
| Placebos | 1 | 2018 | 195 | 0.160 |
Why?
|
| Stroke Rehabilitation | 1 | 2022 | 334 | 0.160 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 211 | 0.150 |
Why?
|
| Electric Stimulation Therapy | 1 | 2019 | 147 | 0.150 |
Why?
|
| Iron | 1 | 2018 | 197 | 0.150 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 237 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2020 | 310 | 0.140 |
Why?
|
| Amygdala | 2 | 2015 | 159 | 0.140 |
Why?
|
| Electroencephalography | 1 | 2019 | 418 | 0.140 |
Why?
|
| Systems Theory | 1 | 2015 | 13 | 0.140 |
Why?
|
| Pain | 2 | 2013 | 472 | 0.140 |
Why?
|
| Heart Rate | 1 | 2018 | 568 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 445 | 0.130 |
Why?
|
| Smokers | 1 | 2017 | 198 | 0.130 |
Why?
|
| Hippocampus | 2 | 2022 | 471 | 0.130 |
Why?
|
| Parahippocampal Gyrus | 1 | 2014 | 15 | 0.130 |
Why?
|
| Globus Pallidus | 1 | 2014 | 64 | 0.120 |
Why?
|
| Organ Size | 1 | 2014 | 242 | 0.120 |
Why?
|
| Image Enhancement | 1 | 2014 | 143 | 0.120 |
Why?
|
| Recurrence | 1 | 2016 | 948 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 258 | 0.120 |
Why?
|
| Postoperative Period | 1 | 2013 | 238 | 0.110 |
Why?
|
| Naloxone | 1 | 2013 | 56 | 0.110 |
Why?
|
| Aged | 6 | 2021 | 14842 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 137 | 0.110 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2013 | 92 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2323 | 0.110 |
Why?
|
| Analgesia | 1 | 2013 | 58 | 0.110 |
Why?
|
| Marijuana Abuse | 1 | 2015 | 251 | 0.110 |
Why?
|
| Individuality | 1 | 2012 | 44 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 699 | 0.100 |
Why?
|
| Methamphetamine | 1 | 2013 | 132 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2012 | 218 | 0.100 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 438 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2013 | 221 | 0.100 |
Why?
|
| Gambling | 1 | 2010 | 7 | 0.100 |
Why?
|
| Neuropsychological Tests | 2 | 2010 | 517 | 0.100 |
Why?
|
| Pain Management | 1 | 2013 | 186 | 0.100 |
Why?
|
| Drug-Seeking Behavior | 1 | 2013 | 213 | 0.090 |
Why?
|
| Retrospective Studies | 2 | 2021 | 7264 | 0.090 |
Why?
|
| Age Factors | 1 | 2014 | 1860 | 0.090 |
Why?
|
| Prognosis | 1 | 2013 | 2093 | 0.080 |
Why?
|
| Haplorhini | 2 | 2022 | 44 | 0.080 |
Why?
|
| Decision Making | 1 | 2010 | 410 | 0.080 |
Why?
|
| Time Factors | 2 | 2016 | 4655 | 0.070 |
Why?
|
| Task Performance and Analysis | 2 | 2005 | 150 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 782 | 0.070 |
Why?
|
| Time | 1 | 2005 | 57 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2010 | 1329 | 0.060 |
Why?
|
| Arm | 1 | 2005 | 59 | 0.060 |
Why?
|
| Middle Cerebral Artery | 1 | 2005 | 57 | 0.060 |
Why?
|
| Discriminant Analysis | 1 | 2004 | 36 | 0.060 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 65 | 0.060 |
Why?
|
| Physical Stimulation | 2 | 2019 | 67 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2022 | 62 | 0.050 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2021 | 13 | 0.050 |
Why?
|
| Upper Extremity | 1 | 2022 | 112 | 0.050 |
Why?
|
| Trichotillomania | 1 | 2021 | 14 | 0.050 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2021 | 88 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2004 | 705 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 1753 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2020 | 203 | 0.050 |
Why?
|
| Random Allocation | 1 | 2021 | 442 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 252 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2021 | 183 | 0.040 |
Why?
|
| Adolescent | 3 | 2021 | 8903 | 0.040 |
Why?
|
| Wrist | 1 | 2019 | 24 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2013 | 1737 | 0.040 |
Why?
|
| Vibration | 1 | 2019 | 32 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 116 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 951 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2022 | 506 | 0.040 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 143 | 0.040 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 154 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 346 | 0.040 |
Why?
|
| Algorithms | 1 | 2022 | 1194 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2264 | 0.030 |
Why?
|
| Aftercare | 1 | 2016 | 114 | 0.030 |
Why?
|
| Neurons | 1 | 2020 | 881 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2016 | 111 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 1515 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2013 | 257 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 5300 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2013 | 259 | 0.030 |
Why?
|
| Narcotic Antagonists | 1 | 2013 | 184 | 0.030 |
Why?
|
| Seizures | 1 | 2013 | 279 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2013 | 435 | 0.020 |
Why?
|
| Child | 1 | 2020 | 6400 | 0.020 |
Why?
|
| Species Specificity | 1 | 2008 | 302 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 1039 | 0.020 |
Why?
|
| South Carolina | 1 | 2013 | 2750 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 55 | 0.020 |
Why?
|
| Osteoarthritis, Knee | 1 | 2005 | 26 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2005 | 219 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2005 | 55 | 0.020 |
Why?
|
| Anxiety | 1 | 2005 | 422 | 0.010 |
Why?
|
| Depression | 1 | 2005 | 942 | 0.010 |
Why?
|